The anti-aging serum market is projected to exceed USD 18 billion by 2030, and retinoids remain the most researched category of active ingredients for visible skin aging concerns. For private label brands and OEM buyers, choosing between retinal, retinol, and bakuchiol determines your product's positioning, claims, pricing power, and regulatory pathway. This guide breaks down the mechanism, concentration limits, stability requirements, and formulation considerations for each ingredient so you can make informed sourcing decisions.
Retinoids are a family of vitamin A derivatives that interact with nuclear receptors in skin cells to influence gene expression related to cell turnover and collagen metabolism. According to the American Academy of Dermatology, topical retinoids are among the most studied compounds in dermatology for addressing visible signs of photoaging.
The conversion pathway determines both potency and tolerability. Retinyl esters (the weakest form) must convert to retinol, which converts to retinal (retinaldehyde), which finally converts to retinoic acid — the only form that directly binds to retinoic acid receptors (RARs) in the skin.
Each conversion step reduces bioavailability. Retinyl esters require three conversion steps, retinol requires two, and retinal requires just one. This single-step conversion is why retinal may help support faster visible results while maintaining a favorable tolerability profile compared to prescription-only retinoic acid.
For OEM buyers, the practical implication is straightforward: retinal-based formulations can deliver a competitive differentiation point — positioned as more effective than retinol without requiring a prescription.
Retinal, or retinaldehyde, sits closest to retinoic acid in the metabolic pathway. Research published in the British Journal of Dermatology suggests that retinaldehyde may help support visible improvements in skin texture and the appearance of fine lines at concentrations as low as 0.05%, thanks to its direct conversion advantage.
Retinaldehyde is converted to retinoic acid by retinaldehyde dehydrogenase enzymes present in keratinocytes. Because only one enzymatic step is needed, retinal can achieve receptor activation at lower concentrations compared to retinol.
Retinal remains relatively underutilized in the mass market compared to retinol. A search of major e-commerce platforms shows that retinol-based products outnumber retinal-based products by roughly 20:1. This supply gap represents a whitespace opportunity for private label brands — a retinal serum can be positioned as a premium, next-generation anti-aging product with a clear and defensible ingredient story.
Retinol is the most widely used non-prescription retinoid in cosmetic formulations. It has decades of published research supporting its role in formulations designed to address the appearance of fine lines, uneven skin tone, and visible texture concerns.
Retinol undergoes two-step enzymatic conversion: first to retinaldehyde by retinol dehydrogenase, then to retinoic acid by retinaldehyde dehydrogenase. Research reviewed by the Cosmetic Ingredient Review (CIR) Expert Panel confirms that topically applied retinol is metabolized to retinoic acid in the epidermis, where it may help influence keratinocyte differentiation and collagen metabolism.
Retinol remains the dominant non-prescription retinoid by volume. Consumer familiarity is high, but so is market saturation. Differentiation in the retinol space increasingly depends on delivery system innovation (encapsulation claims), companion ingredients, and packaging quality — rather than the retinol concentration alone.
Bakuchiol is a meroterpene phenol extracted from the seeds and leaves of Psoralea corylifolia (babchi plant). It has gained attention as a plant-derived ingredient that may offer retinol-like visible benefits through a different biological mechanism.
Unlike retinoids, bakuchiol does not bind to retinoic acid receptors. A 2014 study published in the British Journal of Dermatology found that bakuchiol may help regulate gene expression through pathways that partially overlap with retinol-regulated genes, while showing different receptor-binding behavior.
Bakuchiol benefits from strong "natural" and "clean beauty" consumer associations. Multiple consumer surveys indicate that bakuchiol is frequently described as a "gentle retinol alternative" by end consumers, which can simplify marketing for brands targeting the sensitive-skin or natural-product segments.
Regulatory frameworks differ across markets, and brand owners must verify the specific limits applicable to their target countries.
| Market | Retinol Limit | Retinal Limit | Bakuchiol Limit | Key Reference |
|---|---|---|---|---|
| EU (EC 1223/2009) | ≤ 0.3% face, ≤ 0.05% body | Subject to safety assessment | No specific restriction | SCCS Opinion |
| US (FDA) | No statutory limit; CIR ≤ 1.0% | No specific guidance | No specific guidance | CIR Final Report |
| Canada (Health Canada) | ≤ 1.0% | Subject to notification | Subject to notification | Ingredient Hotlist |
| ASEAN | Aligns with EU | Aligns with EU | No specific restriction | ASEAN Cosmetic Directive |
Note: The EU's Scientific Committee on Consumer Safety (SCCS) has issued opinions limiting retinol concentration, which may be adopted into the Cosmetics Regulation. Brands targeting EU markets should monitor these developments closely and verify the latest published limits before finalizing formulations.
Modern anti-aging serums rarely rely on a single active ingredient. Understanding ingredient compatibility is essential for formulating stable, effective products.
The Private Label Retinal Skin Booster Serum (PS20-SP) combines retinal, retinol, and bakuchiol with hyaluronic acid, vitamin C, and vitamin E — a formulation approach that layers multiple anti-aging actives. The product is supplied in 15ml to 100ml sizes, with OEM customization available for ingredient ratios, packaging design, and branding. Available certifications include ISO22716, GMP, and MSDS.
The single biggest formulation risk with retinoid products is degradation before the consumer finishes the product.
| Packaging Feature | Retinol | Retinal | Bakuchiol |
|---|---|---|---|
| Airless pump | Recommended | Recommended | Optional |
| Opaque/UV-protective | Essential | Essential | Recommended |
| Clear glass jar | Not recommended | Not recommended | Acceptable (short term) |
Brands sourcing OEM retinoid serums should request accelerated stability testing (40°C / 75% RH, 3–6 months), real-time stability testing (25°C / 60% RH for claimed shelf life), photostability testing, and retinoid content assay at multiple time points. A supplier's ability to provide these test reports is a practical signal of their formulation maturity and quality control capability.
Formulators often pair retinoids with antioxidant systems to extend shelf life. Common approaches include:
When evaluating a supplier's formula, ask which antioxidant system is used and request compatibility data showing the antioxidant package does not interfere with the retinoid's bioavailability.
Retinoid degradation is temperature-dependent. At 40°C, unprotected retinol can lose over 40% of its activity within four weeks. At 25°C, the same formulation may retain 90%+ potency over three months. This is why storage and shipping conditions matter — confirm with suppliers that products are shipped under temperature-controlled conditions when possible, and that accelerated testing data reflects realistic worst-case scenarios for your distribution channels.
When sourcing a retinal or retinoid serum from an OEM supplier, look beyond the price per unit.
Q: Which is more effective — retinal or retinol?
Retinal requires only one enzymatic conversion step to reach retinoic acid, compared to two steps for retinol. This difference means retinal may produce faster visible results at comparable concentrations. For brand positioning, retinal offers a "next-generation retinoid" narrative.
Q: Is bakuchiol a true replacement for retinol?
Bakuchiol does not share the same mechanism of action as retinol — it does not bind to retinoic acid receptors. Its primary advantage is stability and suitability for sensitive-skin product lines, not equivalent potency.
Q: What MOQ should I expect for a custom retinal serum?
For a custom-formulated retinal serum with branded packaging, expect MOQ ranges of 500–1000 pieces for standard customization and 3000 pieces or more for specialized packaging. Stock formula MOQs may start as low as 100 pieces.
Q: Can retinal, retinol, and bakuchiol be formulated together?
Yes. Because bakuchiol does not compete for the same receptor sites as retinoids, combination formulations are feasible. The Lanthome Retinal Skin Booster Serum is one example of a product that combines all three.
Q: What certifications should I look for when sourcing retinoid serums?
At minimum, verify ISO 22716 (GMP for cosmetics) and MSDS documentation. For EU-bound products, confirm compliance with EC 1223/2009. Third-party testing from SGS or Intertek adds credibility.
Q: How do I ensure retinoid concentration stays stable through shelf life?
Request stability testing data from the supplier, confirm airless and opaque packaging, and consider independent third-party testing of retained samples at 6-month intervals.
Q: How should I position retinal vs. retinol in my brand's product line?
Retinal serums can be positioned as a premium tier above retinol — the "next-generation" anti-aging option for consumers who want faster visible results without prescription-strength products. Retinol remains the volume play: familiar, clinically referenced, and price-competitive. Bakuchiol fills the sensitive-skin and natural-product niche. A three-tier retinoid product line (bakuchiol → retinol → retinal) can cover the full price and efficacy spectrum for a private label brand.
Q: What are the most common mistakes brands make when sourcing retinoid serums?
Three recurring issues: (1) Choosing a formula based on ingredient lists without verifying active concentration or stability data — a serum can list retinol at 0.5% on the label but deliver less than 0.1% after three months of shelf life without adequate stabilization. (2) Overlooking packaging compatibility — a beautiful jar design that exposes the formula to air and light can undermine even the best-stabilized retinoid serum. (3) Not requesting a retained sample for independent testing — this is your only defense against batch-to-batch variability.
About the Author
This article was prepared by the Lanthome skincare manufacturing team, with experience in private label formulation, packaging development, quality control, and international OEM/ODM projects.
